Advisory Research’s Inspire Medical Systems INSP Stock Holding History

Advisory Research’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,907	Closed	-$944K	–	452
2023 Q2	$944K	Buy	+2,907	New	+$831K	0.12%	209
2023 Q1	–	Sell	-1,275	Closed	-$321K	–	381
2022 Q4	$321K	Buy	+1,275	New	+$272K	0.03%	290
2021 Q1	–	Sell	-3,719	Closed	-$700K	–	363
2020 Q4	$700K	Sell	3,719 -9,734	-72%	-$1.59M	0.05%	232
2020 Q3	$1.74M	Sell	13,453 -7,928	-37%	-$874K	0.17%	114
2020 Q2	$1.86M	Sell	21,381 -9,389	-31%	-$722K	0.17%	115
2020 Q1	$1.85M	Sell	30,770 -1,675	-5%	-$124K	0.13%	92
2019 Q4	$2.41M	Buy	32,445 +9,287	+40%	+$597K	0.11%	110
2019 Q3	$1.41M	Sell	23,158 -3,019	-12%	-$199K	0.07%	146
2019 Q2	$1.59M	Buy	+26,177	New	+$1.41M	0.03%	208

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Advisory Research's INSP Position: Q3 2023 in Review

Advisory Research sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 2,907 shares — an estimated $944K sold.

Advisory Research first reported a position in INSP in Q2 2019 and held it in 9 quarters. The position peaked at $2.41M in Q4 2019. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

Advisory Research reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
Advisory Research sold 2,907 Inspire Medical Systems shares in Q3 2023, an estimated $944K.
Advisory Research first reported a position in Inspire Medical Systems in Q2 2019 and held it in 9 quarters.
Advisory Research's Inspire Medical Systems position peaked at $2.41M in Q4 2019.
364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.